story of the week
Baseline Cirrhosis Increases Risk of Hepatocellular Carcinoma Long After HCV Eradication
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Gastroenterology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Increased Risk for Hepatocellular Carcinoma Persists up to 10 Years After HCV Eradication in Patients With Baseline Cirrhosis or High FIB-4 Scores
Gastroenterology 2019 Nov 01;157(5)1264-1278.e4, GN Ioannou, LA Beste, PK Green, AG Singal, EB Tapper, AK Waljee, RK Sterling, JJ Feld, DE Kaplan, TH Taddei, K BerryFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.